CBD is a multi-target molecule that binds with numerous cell receptors throughout the body; thus, it directly and indirectly initiates complex biological changes in the body, mind, and emotions.Â
In 2018, the FDA gave its approval for Epidiolex, a pharmaceutical variation of CBD, to address rare pediatric seizure disorders resistant to traditional anti-epileptic treatments like Lennox-Gastaut syndrome and Dravet syndrome.
The educational information provided is for general informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
